Available: Federal Trade Commission, FTC Brings First-ever Action Targeting IV Cocktail Therapy Marketer, September 20, 2018
Better outcomes with GLP-1s in those with diabetes and peripheral arterial disease July 29, 2026 Summary: In a propensity-matched observational study of 2,133 pairs of patients with type 2 diabetes and peripheral artery disease, those prescribed GLP-1 receptor agonists had lower five-year rates of death, hospitalization, revascularization, and amputation than those prescribed metformin
The 1998 Johansen pharmacokinetic paper characterised plasma half-life and absorption kinetics (PMID 9879640)
Specifically, hemoglobin A1c (or HbA1c), which reflects blood sugar levels over the previous two to three months
Genes are contained on chromosomes
Timing matters for oral Rybelsus users